regulatory submission - Robuta Search

https://www.sgs.com/en-mm/services/food-contact-material-regulatory-submission-service Food Contact Material Regulatory Submission Service | SGS Streamline FDA FCN and Health Canada LONO regulatory authorization for food contact substances in North American markets with SGS. food contact material regulatory submission service sgs https://www.news-medical.net/whitepaper/20200508/Pharmaceutical-Regulatory-Submission-Preparation-and-Management.aspx Pharmaceutical Regulatory Submission Preparation and Management Jul 11, 2024 - Required by a regulatory agency, pharmaceutical regulatory submissions are information packets todetermine whether clinical trials can proceed. regulatory submission pharmaceutical preparation management https://www.gsk.com/en-gb/media/press-releases/gsk-regulatory-submission-for-momelotinib-for-the-treatment-of-myelofibrosis-accepted-for-review-by-japanese-regulator/ GSK regulatory submission for momelotinib for the treatment of myelofibrosis accepted for review by... Submission included data from trials addressing clinical manifestations of myelofibrosis - splenomegaly, constitutional symptoms and anaemia regulatory submission the treatment https://studylib.net/doc/27619311/imdrf-n9--nivd-toc--rps-wg-ed-4-final-v4 nIVD Regulatory Submission Table of Contents (IMDRF) IMDRF's harmonized structure for nIVD regulatory submissions. Covers administrative, clinical, quality, and labeling requirements. table of contents regulatory submission https://assyro.com/ AI Regulatory Submission Software for Life Sciences | Assyro AI AI regulatory submission software for pharma, biotech, and medical device teams. Draft faster, catch eCTD defects earlier, keep filings audit-ready. for life sciences regulatory submission ai software https://www.sanofi.com/en/media-room/press-releases/2021/2021-12-06-13-00-00-2346501 EMA accepts regulatory submission for olipudase alfa, the first potential therapy for ASMD EMA accepts regulatory submission for olipudase alfa, the first potential therapy for ASMD Olipudase alfa has been granted PRIority MEdicines (PRIME)... regulatory submission https://www.biospace.com/amerigen-pharmaceuticals-and-b-dipharma-b-announce-first-regulatory-submission-for-miglustat-100mg-capsules Amerigen Pharmaceuticals And DIPHARMA Announce First Regulatory Submission For Miglustat 100mg... regulatory submission pharmaceuticals announce https://www.prnewswire.co.uk/news-releases/helsinn-announces-european-medicines-agency-acceptance-of-regulatory-submission-for-netupitant-palonosetron-fixed-dose-combination-nepa-242549301.html Helsinn Announces European Medicines Agency Acceptance of Regulatory Submission for... /PRNewswire/ -- NEPA is currently under development for the treatment of chemotherapy-induced nausea and vomiting The Swiss pharmaceutical Helsinn Group... european medicines agency regulatory submission announces acceptance https://www.sgs.com/en-au/services/food-contact-material-regulatory-submission-service Food Contact Material Regulatory Submission Service | SGS Australia Streamline FDA FCN and Health Canada LONO regulatory authorization for food contact substances in North American markets with SGS. food contact material regulatory submission service sgs australia https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-regulatory-submission-for-sirukumab-in-rheumatoid-arthritis/ GSK announces US regulatory submission for sirukumab in rheumatoid arthritis | GSK Sirukumab is being co-developed for RA as part of a collaboration with Janssen Biologics (Ireland) [Janssen], an affiliate of JBI. regulatory submission gsk announces us arthritis https://nla.gov.au/nla.obj-1203510477/view Submission to QCA : Long Term Regulatory Framework for SEQ Water Entities long term regulatory framework submission qca https://www.biospace.com/eli-lilly-announces-update-on-regulatory-submission-timing-for-basal-insulin-peglispro Eli Lilly Announces Update On Regulatory Submission Timing For Basal Insulin Peglispro - BioSpace https://www.biospace.com/update-on-regulatory-submission-for-aducanumab-in-the-european-unionbiogen-to-seek-re-examination-following-chmp-negative-opinion-for-aducanumab Update on Regulatory Submission for Aducanumab in the European UnionBiogen to seek re-examination... Dec 17, 2021 - Biogen Inc. (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European... https://www.racgp.org.au/advocacy/reports-and-submissions/view-all-reports-and-submissions/2020-reports-and-submissions/financial-technology-and-regulatory-technology RACGP - Submission to the Senate Select Committee on Financial Technology and Regulatory Technology The RACGP has provided a submission to the Senate Select Committee on Financial Technology and Regulatory Technology to the select committee https://www.sanofi.com/en/media-room/press-releases/2026/2026-04-22-05-00-00-3278646 Press Release: Sanofi provides update on the regulatory submission for Sarclisa subcutaneous in the... Sanofi provides update on the regulatory submission for Sarclisa subcutaneous in the US Paris, April 22, 2026. The US Food and Drug Administration (FDA) has... https://www.greenpeace.org/aotearoa/story/submission-guide-regulatory-standards-bill/ Regulatory Standards Bill submission guide - Greenpeace Aotearoa Jul 11, 2025 - This is a handy guide to help you make your submission before 1pm Monday 23 June. It covers what the bill is, why you should make a submission and how you can... regulatory standards submission guide bill greenpeace aotearoa https://www.fda.gov/regulatory-information/search-fda-guidance-documents/providing-regulatory-submissions-electronic-format-submission-manufacturing-establishment Providing Regulatory Submissions in Electronic Format--Submission of Manufacturing Establishment... Guidance for Industy regulatory submissions providing electronic format manufacturing https://www.racgp.org.au/advocacy/reports-and-submissions/view-all-reports-and-submissions/2023-reports-and-submissions/submission-on-the-regulatory-options-to-allow-refe RACGP - Submission on the Regulatory options to allow references to the TGA in therapeutic goods... 5 December 2022 - The RACGP has provided a response to the Department of Health and Aged Care on the Regulatory options to allow references to the TGA in... https://www.prnewswire.co.uk/news-releases/astellas-files-regulatory-submission-for-ec905---a-new-fixed-dose-combination-treatment-for-male-luts-144539675.html Astellas Files Regulatory Submission for EC905 - A New Fixed Dose Combination Treatment for Male... /PRNewswire/ -- ASTELLAS PHARMA EUROPE Ltd., the European subsidiary of Tokyo - based Astellas Pharma Inc. (Tokyo:4503) today announced the submission of a... https://www.fiercebiotech.com/biotech/akeso-scores-twice-pair-phase-3-trials-teeing-regulatory-submission Akeso scores twice in phase 3, tees up regulatory submission Aug 25, 2025 - Akeso is adding a pair of late-stage wins to its scorecard in both ankylosing spondylitis and atopic dermatitis. scores twice phase tees regulatory https://www.biospace.com/press-releases/satellos-announces-ind-submission-to-the-u-s-fda-and-global-regulatory-filings-to-advance-a-phase-2-clinical-trial-of-sat-3247-in-children-with-duchenne-muscular-dystrophy Satellos Announces IND Submission to the U.S. FDA and Global Regulatory Filings to Advance a Phase... https://www.gsk.com/en-gb/media/press-releases/gsk-files-eu-regulatory-submission-for-once-daily-closed-triple-combination-therapy-ffumecvi-for-patients-with-copd/ GSK files EU regulatory submission for once-daily closed triple combination therapy FF/UMEC/VI for... The filing by GSK of a regulatory submission closed triple combination therapy FF/UMEC/VI 100/62.5/25 mcg for patients with COPD. https://www.prnewswire.com/news-releases/daiichi-sankyo-advances-fam--trastuzumab-deruxtecan-ds-8201-in-japan-with-regulatory-submission-in-her2-positive-metastatic-breast-cancer-300913893.html Daiichi Sankyo Advances [Fam-] Trastuzumab Deruxtecan (DS-8201) in Japan with Regulatory Submission... /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the submission of a New Drug Application (NDA) to Japan's...